STATs in cancer inflammation and immunity: a leading role for STAT3 (original) (raw)

• Mantovani, A., Allavena, P., Sica, A. & Balkwill, F. Cancer-related inflammation. Nature 454, 436–444 (2008).
  Article CAS PubMed Google Scholar
• Catlett-Falcone, R. et al. Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells. Immunity 10, 105–115 (1999). This report was the first to document that IL-6–JAK–STAT3 signalling, which increases inflammation-induced cancer, is important for the growth and survival of human tumour cells.
  Article CAS PubMed Google Scholar
• Bollrath, J. et al. gp130-mediated Stat3 activation in enterocytes regulates cell survival and cell-cycle progression during colitis-associated tumorigenesis. Cancer Cell 15, 91–102 (2009).
  Article CAS PubMed Google Scholar
• Kujawski, M. et al. Stat3 mediates myeloid cell-dependent tumor angiogenesis in mice. J. Clin. Invest. 118, 3367–3377 (2008). This study demonstrated that STAT3 is a crucial mediator for myeloid cell-induced tumour angiogenesis.
  Article CAS PubMed PubMed Central Google Scholar
• Kortylewski, M. et al. Regulation of the IL-23 and IL-12 balance by Stat3 signaling in the tumor microenvironment. Cancer Cell 15, 114–123 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Wang, L., Yi, T., Kortylewski, M., Pardoll, D., Zeng, D., Yu, H. IL-17 can promote tumor growth through an IL-6/Stat3 signaling pathway. J. Exp. Med. 206, 1457–1464 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Grivennikov, S. et al. IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. Cancer Cell 15, 103–113 (2009). Studies reported in references 3 and 7 identified STAT3 as a central node for inflammation-induced cancer, suggesting that it is a crucial target for treating and preventing cancer-promoting inflammation.
  Article CAS PubMed PubMed Central Google Scholar
• Shain, K. H. et al. β1 integrin adhesion enhances IL-6-mediated STAT3 signaling in myeloma cells: implications for microenvironment influence on tumor survival and proliferation. Cancer Res. 69, 1009–1015 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Ara, T. et al. Interleukin-6 in the bone marrow microenvironment promotes the growth and survival of neuroblastoma cells. Cancer Res. 69, 329–337 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Gao, S. P. et al. Mutations in the EGFR kinase domain mediate STAT3 activation via IL-6 production in human lung adenocarcinomas. J. Clin. Invest. 117, 3846–3856 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Olcaydu, D. et al. A common JAK2 haplotype confers susceptibility to myeloproliferative neoplasms. Nature Genet. 41, 450–454 (2009).
  Article CAS PubMed Google Scholar
• Rebouissou, S. et al. Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours. Nature 457, 200–204 (2009). This study provides excellent examples of genetic mutations activating the IL-6–GP130–JAK–STAT3 pathway leading to inflammation-associated human cancer.
  Article CAS PubMed Google Scholar
• Ernst, M. et al. STAT3 and STAT1 mediate IL-11-dependent and inflammation-associated gastric tumorigenesis in gp130 receptor mutant mice. J. Clin. Invest. 118, 1727–1738 (2008).
  CAS PubMed PubMed Central Google Scholar
• Arredondo, J., Chernyavsky, A. I., Jolkovsky, D. L., Pinkerton, K. E. & Grando, S. A. Receptor-mediated tobacco toxicity: cooperation of the Ras/Raf-1/MEK1/ERK and JAK-2/STAT-3 pathways downstream of alpha7 nicotinic receptor in oral keratinocytes. FASEB J. 20, 2093–2101 (2006).
  Article CAS PubMed Google Scholar
• Gu, M., Singh, R. P., Dhanalakshmi, S., Agarwal, C. & Agarwal, R. Silibinin inhibits inflammatory and angiogenic attributes in photocarcinogenesis in SKH-1 hairless mice. Cancer Res. 67, 3483–3491 (2007).
  Article CAS PubMed Google Scholar
• Aziz, M. H., Manoharan, H. T. & Verma, A. K. Protein kinase C epsilon, which sensitizes skin to sun's UV radiation-induced cutaneous damage and development of squamous cell carcinomas, associates with Stat3. Cancer Res. 67, 1385–1394 (2007).
  Article CAS PubMed Google Scholar
• Bronte-Tinkew, D. M. et al. Helicobacter pylori cytotoxin-associated gene A activates the signal transducer and activator of transcription 3 pathway in vitro and in vivo. Cancer Res. 69, 632–639 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Landen, C. N. Jr, et al. Neuroendocrine modulation of signal transducer and activator of transcription-3 in ovarian cancer. Cancer Res. 67, 10389–10396 (2007).
  Article CAS PubMed Google Scholar
• Samavati, L. et al. STAT3 tyrosine phosphorylation is critical for interleukin 1β and interleukin-6 production in response to lipopolysaccharide and live bacteria. Mol. Immunol. 46, 1867–1877 (2009).
  Article CAS PubMed Google Scholar
• Chan, K. S. et al. Disruption of Stat3 reveals a critical role in both the initiation and the promotion stages of epithelial carcinogenesis. J. Clin. Invest. 114, 720–728 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Migone, T. S. et al. Constitutively activated Jak-STAT pathway in T cells transformed with HTLV-I. Science 269, 79–81 (1995).
  Article CAS PubMed Google Scholar
• Sano, S. et al. Signal transducer and activator of transcription 3 is a key regulator of keratinocyte survival and proliferation following UV irradiation. Cancer Res. 65, 5720–5729 (2005).
  Article CAS PubMed Google Scholar
• Karin, M. & Greten, F. R. NF-κB: linking inflammation and immunity to cancer development and progression. Nature Rev. Immunol. 5, 749–759 (2005).
  Article CAS Google Scholar
• Pikarsky, E. et al. NF-κB functions as a tumour promoter in inflammation-associated cancer. Nature 431, 461–466 (2004).
  Article CAS PubMed Google Scholar
• Baud, V. & Karin, M. Is NF-κB a good target for cancer therapy? Hopes and pitfalls. Nature Rev. Drug Discov. 8, 33–40 (2009).
  Article CAS Google Scholar
• Darnell, J. E. Jr. Transcription factors as targets for cancer therapy. Nature Rev. Cancer 2, 740–749 (2002).
  Article CAS Google Scholar
• Yu, H. & Jove, R. The STATs of cancer — new molecular targets come of age. Nature Rev. Cancer 4, 97–105 (2004).
  Article CAS Google Scholar
• Yu, H., Kortylewski, M. & Pardoll, D. Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment. Nature Rev. Immunol. 7, 41–51 (2007).
  Article CAS Google Scholar
• Zhong, Z., Wen, Z. & Darnell, J. E. Jr. Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. Science 264, 95–98 (1994).
  Article CAS PubMed Google Scholar
• Darnell, J. E. Jr, Kerr, I. M. & Stark, G. R. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264, 1415–1421 (1994).
  Article CAS PubMed Google Scholar
• Bromberg, J. F. et al. Stat3 as an oncogene. Cell 98, 295–303 (1999). This report was the first to demonstrate that Stat3 has intrinsic oncogenic potential.
  Article CAS PubMed Google Scholar
• Lee, H. et al. Persistently activated Stat3 maintains constitutive NF-κB activity in tumors. Cancer Cell 15, 283–293 (2009). This study revealed how STAT3 directly interacts with RELA and facilitates its acetylation by p300, leading to prolonged NF-κB nuclear retention in both tumour cells and tumour-associated immune cells.
  Article CAS PubMed PubMed Central Google Scholar
• Lu, T. & Stark, G. R. Cytokine overexpression and constitutive NFκB in cancer. Cell Cycle 3, 1114–1117 (2004).
  CAS PubMed Google Scholar
• Welte, T. et al. STAT3 deletion during hematopoiesis causes Crohn's disease-like pathogenesis and lethality: a critical role of STAT3 in innate immunity. Proc. Natl Acad. Sci. USA 100, 1879–1884 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Yang, J. et al. Unphosphorylated STAT3 accumulates in response to IL-6 and activates transcription by binding to NFκB. Genes Dev. 21, 1396–1408 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Basseres, D. S. & Baldwin, A. S. Nuclear factor-κB and inhibitor of κB kinase pathways in oncogenic initiation and progression. Oncogene 25, 6817–6830 (2006).
  Article CAS PubMed Google Scholar
• Haura, E. B., Turkson, J. & Jove, R. Mechanisms of disease: insights into the emerging role of signal transducers and activators of transcription in cancer. Nature. Clin. Pract. Oncol. 2, 315–324 (2005).
  Article CAS Google Scholar
• Heinrich, P. C., Behrmann, I., Muller-Newen, G., Schaper, F. & Graeve, L. Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway. Biochem. J. 334 (Pt 2), 297–314 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Ogura, H. et al. Interleukin-17 promotes autoimmunity by triggering a positive-feedback loop via interleukin-6 induction. Immunity 29, 628–636 (2008).
  Article CAS PubMed Google Scholar
• Akira, S. et al. Molecular cloning of APRF, a novel IFN-stimulated gene factor 3 p91-related transcription factor involved in the gp130-mediated signaling pathway. Cell 77, 63–71 (1994).
  Article CAS PubMed Google Scholar
• Dunn, G. P. et al. A critical function for type I interferons in cancer immunoediting. Nature Immunol. 6, 722–729 (2005).
  Article CAS Google Scholar
• Blattman, J. N. & Greenberg, P. D. Cancer immunotherapy: a treatment for the masses. Science 305, 200–205 (2004).
  Article CAS PubMed Google Scholar
• Pardoll, D. M. Spinning molecular immunology into successful immunotherapy. Nature Rev. Immunol. 2, 227–238 (2002).
  Article CAS Google Scholar
• Kaplan, D. H. et al. Demonstration of an interferon γ-dependent tumor surveillance system in immunocompetent mice. Proc. Natl Acad. Sci. USA 95, 7556–7561 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Koebel, C. M. et al. Adaptive immunity maintains occult cancer in an equilibrium state. Nature 450, 903–907 (2007). This paper demonstrates the important role of adaptive immunity in controlling tumour outgrowth.
  Article CAS PubMed Google Scholar
• Galon, J. et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 313, 1960–1964 (2006).
  Article CAS PubMed Google Scholar
• Dunn, G. P., Koebel, C. M. & Schreiber, R. D. Interferons, immunity and cancer immunoediting. Nature Rev. Immunol. 6, 836–848 (2006).
  Article CAS Google Scholar
• Sasaki, K. et al. Stat6 signaling suppresses VLA-4 expression by CD8+ T cells and limits their ability to infiltrate tumor lesions in vivo. J. Immunol. 181, 104–108 (2008).
  Article CAS PubMed Google Scholar
• Ostrand-Rosenberg, S. & Sinha, P. Myeloid-derived suppressor cells: linking inflammation and cancer. J. Immunol. 182, 4499–4506 (2009).
  Article CAS PubMed Google Scholar
• Kortylewski, M. et al. Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity. Nature Med. 11, 1314–1321 (2005). This was the first report to show that STAT3 is persistently activated in tumour-associated immune cells, leading to the suppression of anti-tumour innate and adaptive immune responses.
  Article CAS PubMed Google Scholar
• Cheng, F. et al. A critical role for Stat3 signaling in immune tolerance. Immunity 19, 425–436 (2003).
  Article CAS PubMed Google Scholar
• Cheng, P. et al. Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein. J. Exp. Med. 205, 2235–49 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Ho, H. H. & Ivashkiv, L. B. Role of STAT3 in type I interferon responses. Negative regulation of STAT1-dependent inflammatory gene activation. J. Biol. Chem. 281, 14111–14118 (2006).
  Article CAS PubMed Google Scholar
• Trinchieri, G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nature Rev. Immunol. 3, 133–146 (2003).
  Article CAS Google Scholar
• Matsumura, Y. et al. Selective expansion of foxp3-positive regulatory T cells and immunosuppression by suppressors of cytokine signaling 3-deficient dendritic cells. J. Immunol. 179, 2170–2179 (2007).
  Article CAS PubMed Google Scholar
• Chen, Z. et al. Selective regulatory function of Socs3 in the formation of IL-17-secreting T cells. Proc. Natl Acad. Sci. USA 103, 8137–8142 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Chen, Z. & O'Shea, J. J. Th17 cells: a new fate for differentiating helper T cells. Immunol. Res. 41, 87–102 (2008).
  Article CAS PubMed Google Scholar
• Wu, S. et al. A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nature Med. 15, 1016–1022 (2009).
  Article CAS PubMed Google Scholar
• Schindler, C., Levy, D. E. & Decker, T. JAK-STAT signaling: from interferons to cytokines. J. Biol. Chem. 282, 20059–20063 (2007).
  Article CAS PubMed Google Scholar
• Takeda, K. & Akira, S. STAT family of transcription factors in cytokine-mediated biological responses. Cytokine Growth Factor Rev. 11, 199–207 (2000).
  Article CAS PubMed Google Scholar
• Stark, G. R., Kerr, I. M., Williams, B. R., Silverman, R. H. & Schreiber, R. D. How cells respond to interferons. Annu. Rev. Biochem. 67, 227–264 (1998).
  Article CAS PubMed Google Scholar
• Darnell, J. E., Jr. Studies of IFN-induced transcriptional activation uncover the Jak-Stat pathway. J. Interferon Cytokine Res. 18, 549–554 (1998).
  Article CAS PubMed Google Scholar
• Taga, T. & Kishimoto, T. Gp130 and the interleukin-6 family of cytokines. Annu. Rev. Immunol. 15, 797–819 (1997).
  Article CAS PubMed Google Scholar
• Hirano, T., Ishihara, K. & Hibi, M. Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors. Oncogene 19, 2548–2556 (2000).
  Article CAS PubMed Google Scholar
• Levy, D. E. & Darnell, J. E., Jr. Stats: transcriptional control and biological impact. Nature Rev. Mol. Cell Biol. 3, 651–662 (2002).
  Article CAS Google Scholar
• Heinrich, P. C. et al. Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem. J. 374, 1–20 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Chin, Y. E. et al. Cell growth arrest and induction of cyclin-dependent kinase inhibitor p21 WAF1/CIP1 mediated by STAT1. Science 272, 719–722 (1996).
  Article CAS PubMed Google Scholar
• Shen, Y., Devgan, G., Darnell, J. E., Jr, & Bromberg, J. F. Constitutively activated Stat3 protects fibroblasts from serum withdrawal and UV-induced apoptosis and antagonizes the proapoptotic effects of activated Stat1. Proc. Natl Acad. Sci. USA 98, 1543–1548 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Leung, S., Qureshi, S. A., Kerr, I. M., Darnell, J. E., Jr & Stark, G. R. Role of STAT2 in the alpha interferon signaling pathway. Mol. Cell. Biol. 15, 1312–1317 (1995).
  Article CAS PubMed PubMed Central Google Scholar
• Li, Y. et al. Activation of the signal transducers and activators of the transcription 3 pathway in alveolar epithelial cells induces inflammation and adenocarcinomas in mouse lung. Cancer Res. 67, 8494–8503 (2007).
  Article CAS PubMed Google Scholar
• Judd, L. M. et al. STAT3 activation regulates growth, inflammation, and vascularization in a mouse model of gastric tumorigenesis. Gastroenterology 131, 1073–1085 (2006).
  Article CAS PubMed Google Scholar
• Ogata, H. et al. Deletion of the SOCS3 gene in liver parenchymal cells promotes hepatitis-induced hepatocarcinogenesis. Gastroenterology 131, 179–193 (2006).
  Article CAS PubMed Google Scholar
• Dauer, D. J. et al. Stat3 regulates genes common to both wound healing and cancer. Oncogene 24, 3397–3408 (2005).
  Article CAS PubMed Google Scholar
• Grandis, J. R. et al. Requirement of Stat3 but not Stat1 activation for epidermal growth factor receptor- mediated cell growth in vitro. J. Clin. Invest. 102, 1385–1392 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Trevino, J. G. et al. Src activation of Stat3 is an independent requirement from NF-κB activation for constitutive IL-8 expression in human pancreatic adenocarcinoma cells. Angiogenesis 9, 101–110 (2006).
  Article CAS PubMed Google Scholar
• Bowman, T. et al. Stat3-mediated Myc expression is required for Src transformation and PDGF-induced mitogenesis. Proc. Natl Acad. Sci. USA 98, 7319–7324 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Yu, C. L. et al. Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoprotein. Science 269, 81–83 (1995). This was the first report of persistent activation of STAT3 signalling by a specific oncoprotein in transformed cells.
  Article CAS PubMed Google Scholar
• Lo, H. W. et al. Nuclear interaction of EGFR and STAT3 in the activation of the iNOS/NO pathway. Cancer Cell 7, 575–589 (2005).
  Article CAS PubMed Google Scholar
• Lin, T. S., Mahajan, S. & Frank, D. A. STAT signaling in the pathogenesis and treatment of leukemias. Oncogene 19, 2496–2504 (2000).
  Article CAS PubMed Google Scholar
• Battle, T. E. & Frank, D. A. The role of STATs in apoptosis. Curr. Mol. Med. 2, 381–392 (2002).
  Article CAS PubMed Google Scholar
• Bruns, H. A. & Kaplan, M. H. The role of constitutively active Stat6 in leukemia and lymphoma. Crit. Rev. Oncol. Hematol. 57, 245–253 (2006).
  Article PubMed Google Scholar
• Skinnider, B. F., Kapp, U. & Mak, T. W. The role of interleukin 13 in classical Hodgkin lymphoma. Leuk. Lymphoma 43, 1203–1210 (2002).
  Article CAS PubMed Google Scholar
• Huang, M. et al. Inhibition of Bcr-Abl kinase activity by PD180970 blocks constitutive activation of Stat5 and growth of CML cells. Oncogene 21, 8804–8816 (2002).
  Article CAS PubMed Google Scholar
• Xie, T. X. et al. Activation of stat3 in human melanoma promotes brain metastasis. Cancer Res. 66, 3188–3196 (2006).
  Article CAS PubMed Google Scholar
• Sumimoto, H., Imabayashi, F., Iwata, T. & Kawakami, Y. The BRAF-MAPK signaling pathway is essential for cancer-immune evasion in human melanoma cells. J. Exp. Med. 203, 1651–1656 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Wang, T. et al. Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells. Nature Med. 10, 48–54 (2004).
  Article PubMed CAS Google Scholar
• Dalwadi, H. et al. Cyclooxygenase-2-dependent activation of signal transducer and activator of transcription 3 by interleukin-6 in non-small cell lung cancer. Clin. Cancer Res. 11, 7674–7682 (2005).
  Article CAS PubMed Google Scholar
• Russo, V., Martienssen, R. A, and Riggs, A. D. Epigenetic Mechanisms of Gene Regulation. 662 (Cold Spring Harbor Laboratory Press, USA, 1996).
  Google Scholar
• Zhang, Q., Wang, H. Y., Liu, X. & Wasik, M. A. STAT5A is epigenetically silenced by the tyrosine kinase NPM1-ALK and acts as a tumor suppressor by reciprocally inhibiting NPM1-ALK expression. Nature Med. 13, 1341–1348 (2007).
  Article CAS PubMed Google Scholar
• Choudhari, S. R. et al. Deactivation of Akt and STAT3 signaling promotes apoptosis, inhibits proliferation, and enhances the sensitivity of hepatocellular carcinoma cells to an anticancer agent, Atiprimod. Mol. Cancer Ther. 6, 112–121 (2007).
  Article CAS PubMed Google Scholar
• Sun, S. & Steinberg, B. M. PTEN is a negative regulator of STAT3 activation in human papillomavirus-infected cells. J. Gen. Virol. 83, 1651–1658 (2002).
  Article CAS PubMed Google Scholar
• Muromoto, R. et al. Epstein-Barr virus-derived EBNA2 regulates STAT3 activation. Biochem. Biophys. Res. Commun. 378, 439–443 (2009).
  Article CAS PubMed Google Scholar
• Kortylewski, M. et al. Toll-like receptor 9 activation of signal transducer and activator of transcription 3 constrains its agonist-based immunotherapy. Cancer Res. 69, 2497–2505 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Chiron, D., Bekeredjian-Ding, I., Pellat-Deceunynck, C., Bataille, R. & Jego, G. Toll-like receptors: lessons to learn from normal and malignant human B cells. Blood 112, 2205–2213 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Greten, F. R. et al. IKKβ links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 118, 285–296 (2004).
  Article CAS PubMed Google Scholar
• Groblewska, M. et al. Serum interleukin 6 (IL-6) and C-reactive protein (CRP) levels in colorectal adenoma and cancer patients. Clin. Chem. Lab. Med. 46, 1423–1428 (2008).
  Article CAS PubMed Google Scholar
• Naugler, W. E. et al. Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science 317, 121–124 (2007).
  Article CAS PubMed Google Scholar
• Matsukawa, A. et al. Stat3 in resident macrophages as a repressor protein of inflammatory response. J. Immunol. 175, 3354–3359 (2005).
  Article CAS PubMed Google Scholar
• Pollard, J. W. Tumour-educated macrophages promote tumour progression and metastasis. Nature Rev. Cancer 4, 71–78 (2004).
  Article CAS Google Scholar
• Chang, H. C. et al. Impaired development of human Th1 cells in patients with deficient expression of STAT4. Blood 113, 5887–5890 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Takeda, K. et al. Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. Immunity 10, 39–49 (1999).
  Article CAS PubMed Google Scholar
• Kubo, M., Hanada, T. & Yoshimura, A. Suppressors of cytokine signaling and immunity. Nature Immunol. 4, 1169–1176 (2003).
  Article CAS Google Scholar
• Zou, W. Regulatory T cells, tumour immunity and immunotherapy. Nature Rev. Immunol. 6, 295–307 (2006).
  Article CAS Google Scholar
• Gerosa, F. et al. Differential regulation of interleukin 12 and interleukin 23 production in human dendritic cells. J. Exp. Med. 205, 1447–1461 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Langowski, J. L. et al. IL-23 promotes tumour incidence and growth. Nature 442, 461–465 (2006).
  Article CAS PubMed Google Scholar
• Numasaki, M. et al. Interleukin-17 promotes angiogenesis and tumor growth. Blood 101, 2620–2627 (2003).
  Article CAS PubMed Google Scholar
• Kryczek, I., Wei, S., Szeliga, W., Vatan, L. & Zou, W. Endogenous IL-17 contributes to reduced tumor growth and metastasis. Blood 114, 357–359 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Ghosh, S., May, M. J. & Kopp, E. B. NF-κB and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16, 225–260 (1998).
  Article CAS PubMed Google Scholar
• Karin, M., Cao, Y., Greten, F. R. & Li, Z. W. NF-κB in cancer: from innocent bystander to major culprit. Nature Rev. Cancer 2, 301–310 (2002).
  Article CAS Google Scholar
• Chen, L. F. & Greene, W. C. Shaping the nuclear action of NF-κB. Nature Rev. Mol. Cell Biol. 5, 392–401 (2004).
  Article CAS Google Scholar
• Wang, J. et al. Distinct roles of different NF-κB subunits in regulating inflammatory and T cell stimulatory gene expression in dendritic cells. J. Immunol. 178, 6777–6788 (2007).
  Article CAS PubMed Google Scholar
• Chiarle, R. et al. Stat3 is required for ALK-mediated lymphomagenesis and provides a possible therapeutic target. Nature Med. 11, 623–629 (2005).
  Article CAS PubMed Google Scholar
• Milner, J. D. et al. Impaired TH17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome. Nature 452, 773–776 (2008). This paper demonstrates that STAT3 dominant-negative mutation in individuals with hyper-IgE syndrome is associated with impaired T H 17 cell differentiation.
  Article CAS PubMed PubMed Central Google Scholar
• Minegishi, Y. et al. Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome. Nature 448, 1058–1062 (2007).
  Article CAS PubMed Google Scholar
• Al Khatib, S. et al. Defects along the TH17 differentiation pathway underlie genetically distinct forms of the hyper IgE syndrome. J. Allergy Clin. Immunol. 124, 342–348, (2009).
  Article CAS PubMed Google Scholar
• Sen, B., Saigal, B., Parikh, N., Gallick, G. & Johnson, F. M. Sustained Src inhibition results in signal transducer and activator of transcription 3 (STAT3) activation and cancer cell survival via altered Janus-activated kinase-STAT3 binding. Cancer Res. 69, 1958–1965 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Paez-Ribes, M. et al. Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis. Cancer Cell 15, 220–231 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Turkson, J. et al. Novel peptidomimetic inhibitors of signal transducer and activator of transcription 3 dimerization and biological activity. Mol. Cancer Ther. 3, 261–269 (2004).
  CAS PubMed Google Scholar
• Mandal, P. K. et al. Conformationally constrained peptidomimetic inhibitors of signal transducer and activator of transcription. 3: Evaluation and molecular modeling. J. Med. Chem. 52, 2429–2442 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Turkson, J. et al. Phosphotyrosyl peptides block Stat3-mediated DNA binding activity, gene regulation, and cell transformation. J. Biol. Chem. 276, 45443–45455 (2001).
  Article CAS PubMed Google Scholar
• Siddiquee, K. et al. Selective chemical probe inhibitor of Stat3, identified through structure-based virtual screening, induces antitumor activity. Proc. Natl Acad. Sci. USA 104, 7391–7396 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Schust, J., Sperl, B., Hollis, A., Mayer, T. U. & Berg, T. Stattic: a small-molecule inhibitor of STAT3 activation and dimerization. Chem. Biol. 13, 1235–1242 (2006).
  Article CAS PubMed Google Scholar
• Turkson, J. et al. Inhibition of constitutive signal transducer and activator of transcription 3 activation by novel platinum complexes with potent antitumor activity. Mol. Cancer Ther. 3, 1533–1542 (2004).
  CAS PubMed Google Scholar
• Turkson, J. et al. A novel platinum compound inhibits constitutive Stat3 signaling and induces cell cycle arrest and apoptosis of malignant cells. J. Biol. Chem. 280, 32979–32988 (2005).
  Article CAS PubMed Google Scholar
• Ling, X. & Arlinghaus, R. B. Knockdown of STAT3 expression by RNA interference inhibits the induction of breast tumors in immunocompetent mice. Cancer Res. 65, 2532–2536 (2005).
  Article CAS PubMed Google Scholar
• Leong, P. L. et al. Targeted inhibition of Stat3 with a decoy oligonucleotide abrogates head and neck cancer cell growth. Proc. Natl Acad. Sci. USA 100, 4138–4143 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Barton, B. E., Karras, J. G., Murphy, T. F., Barton, A. & Huang, H. F. Signal transducer and activator of transcription 3 (STAT3) activation in prostate cancer: Direct STAT3 inhibition induces apoptosis in prostate cancer lines. Mol. Cancer Ther. 3, 11–20 (2004).
  Article CAS PubMed Google Scholar
• Kortylewski, M. et al. In vivo delivery of siRNA to immune cells by conjugation to a TLR9 agonist enhances antitumor immune responses. Nature Biotechnol. 27, 925–932 (2009).
  Article CAS Google Scholar
• Sen, M. et al. Lack of toxicity of a STAT3 decoy oligonucleotide. Cancer Chemother. Pharmacol. 63, 983–995 (2009).
  Article CAS PubMed Google Scholar
• Blaskovich, M. A. et al. Discovery of JSI-124 (cucurbitacin I), a selective Janus kinase/signal transducer and activator of transcription 3 signaling pathway inhibitor with potent antitumor activity against human and murine cancer cells in mice. Cancer Res. 63, 1270–1279 (2003).
  CAS PubMed Google Scholar
• Kotha, A. et al. Resveratrol inhibits Src and Stat3 signaling and induces the apoptosis of malignant cells containing activated Stat3 protein. Mol. Cancer Ther. 5, 621–629 (2006).
  Article CAS PubMed Google Scholar
• Nam, S. et al. Indirubin derivatives inhibit Stat3 signaling and induce apoptosis in human cancer cells. Proc. Natl Acad. Sci. USA 102, 5998–6003 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Ghoreschi, K., Laurence, A. & O'Shea, J. J. Selectivity and therapeutic inhibition of kinases: to be or not to be? Nature Immunol. 10, 356–360 (2009).
  Article CAS Google Scholar
• Pesu, M. et al. Therapeutic targeting of Janus kinases. Immunol. Rev. 223, 132–142 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Kong, L. Y. et al. A novel inhibitor of signal transducers and activators of transcription 3 activation is efficacious against established central nervous system melanoma and inhibits regulatory T cells. Clin. Cancer Res. 14, 5759–5768 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Nefedova, Y. et al. Regulation of dendritic cell differentiation and antitumor immune response in cancer by pharmacologic-selective inhibition of the janus-activated kinase 2/signal transducers and activators of transcription 3 pathway. Cancer Res. 65, 9525–9535 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Gozgit, J. M. et al. Effects of the JAK2 inhibitor, AZ960, on Pim/BAD/BCL-xL survival signaling in the human JAK2 V617F cell line SET-2. J. Biol. Chem. 283, 32334–32343 (2008).
  Article CAS PubMed Google Scholar
• Yang, F. et al. Sorafenib inhibits signal transducer and activator of transcription 3 signaling associated with growth arrest and apoptosis of medulloblastomas. Mol. Cancer Ther. 7, 3519–3526 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Xin, H. et al. Sunitinib inhibition of Stat3 induces renal cell carcinoma tumor cell apoptosis and reduces immunosuppressive cells. Cancer Res. 69, 2506–2513 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Ozao-Choy, J. et al. The novel role of tyrosine kinase inhibitor in the reversal of immune suppression and modulation of tumor microenvironment for immune-based cancer therapies. Cancer Res. 69, 2514–2522 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Ko, J. S. et al. Sunitinib mediates reversal of myeloid-derived suppressor cell accumulation in renal cell carcinoma patients. Clin. Cancer Res. 15, 2148–2157 (2009).
  Article CAS PubMed Google Scholar
• Caprioli, F. et al. Autocrine regulation of IL-21 production in human T lymphocytes. J. Immunol. 180, 1800–1807 (2008).
  Article CAS PubMed Google Scholar
• Donnelly, R. P., Dickensheets, H. & Finbloom, D. S. The interleukin-10 signal transduction pathway and regulation of gene expression in mononuclear phagocytes. J. Interferon Cytokine Res. 19, 563–573 (1999).
  Article CAS PubMed Google Scholar
• Lamprecht, B. et al. Aberrant expression of the Th2 cytokine IL-21 in Hodgkin lymphoma cells regulates STAT3 signaling and attracts Treg cells via regulation of MIP-3α. Blood 112, 3339–3347 (2008).
  Article CAS PubMed Google Scholar
• Takatori, H., Kanno, Y., Chen, Z. & O'Shea, J. J. New complexities in helper T cell fate determination and the implications for autoimmune diseases. Mod. Rheumatol. 18, 533–541 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Stout, B. A., Bates, M. E., Liu, L. Y., Farrington, N. N. & Bertics, P. J. IL-5 and granulocyte-macrophage colony-stimulating factor activate STAT3 and STAT5 and promote Pim-1 and cyclin D3 protein expression in human eosinophils. J. Immunol. 173, 6409–6417 (2004).
  Article CAS PubMed Google Scholar
• Zorn, E. et al. IL-2 regulates FOXP3 expression in human CD4+CD25+ regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivo. Blood 108, 1571–1579 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Finkelman, F. D. et al. Interleukin-4- and interleukin-13-mediated host protection against intestinal nematode parasites. Immunol. Rev. 201, 139–155 (2004).
  Article CAS PubMed Google Scholar
• Schuringa, J. J., Timmer, H., Luttickhuizen, D., Vellenga, E. & Kruijer, W. c-Jun and c-Fos cooperate with STAT3 in IL-6-induced transactivation of the IL-6 respone element (IRE). Cytokine 14, 78–87 (2001).
  Article CAS PubMed Google Scholar
• Lo, H. W. et al. Epidermal growth factor receptor cooperates with signal transducer and activator of transcription 3 to induce epithelial-mesenchymal transition in cancer cells via up-regulation of TWIST gene expression. Cancer Res. 67, 9066–9076 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Wu, Y., Diab, I., Zhang, X., Izmailova, E. S. & Zehner, Z. E. Stat3 enhances vimentin gene expression by binding to the antisilencer element and interacting with the repressor protein, ZBP-89. Oncogene 23, 168–178 (2004).
  Article CAS PubMed Google Scholar
• Liu, H. et al. Serine phosphorylation of STAT3 is essential for Mcl-1 expression and macrophage survival. Blood 102, 344–352 (2003).
  Article CAS PubMed Google Scholar
• Madamanchi, N. R., Li, S., Patterson, C. & Runge, M. S. Thrombin regulates vascular smooth muscle cell growth and heat shock proteins via the JAK-STAT pathway. J. Biol. Chem. 276, 18915–18924 (2001).
  Article CAS PubMed Google Scholar
• Bartoli, M. et al. VEGF differentially activates STAT3 in microvascular endothelial cells. FASEB J. 17, 1562–1564 (2003).
  Article CAS PubMed Google Scholar
• Gao, H., Priebe, W., Glod, J. & Banerjee, D. Activation of signal transducers and activators of transcription 3 and focal adhesion kinase by stromal cell-derived factor 1 is required for migration of human mesenchymal stem cells in response to tumor cell-conditioned medium. Stem Cells 27, 857–865 (2009).
  Article CAS PubMed Google Scholar
• Leung, T. H., Hoffmann, A. & Baltimore, D. One nucleotide in a κB site can determine cofactor specificity for NF-κB dimers. Cell 118, 453–464 (2004).
  Article CAS PubMed Google Scholar
• Burysek, L., Syrovets, T. & Simmet, T. The serine protease plasmin triggers expression of MCP-1 and CD40 in human primary monocytes via activation of p38 MAPK and janus kinase (JAK)/STAT signaling pathways. J. Biol. Chem. 277, 33509–33517 (2002).
  Article CAS PubMed Google Scholar